Effect of sulphadoxine-pyrimethamine on neonatal birth weight and perceptions on its impact on malaria in pregnancy in an intermittent preventive treatment programme setting in Offinso District, Ghana

International Health

Volumn 3, Issue 3, 2011, Pages 206-212

  Tutu, Emmanuel Osei ^a   Browne, Edmund ^a   Lawson, Bernard ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Birth Weight; Intermittent preventive treatment; Malaria; Neonates; Pregnancy; Sulphadoxine Pyrimethamine

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE;

ADULT; AGE; ARTICLE; BIRTH WEIGHT; DRUG EFFECT; FEMALE; GENDER; GHANA; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; NEWBORN; NEWBORN MORTALITY; PREGNANCY; PRIORITY JOURNAL; SEASONAL VARIATION;

EID: 80052452794     PISSN: 18763413     EISSN: 18763405     Source Type: Journal    
DOI: 10.1016/j.inhe.2011.04.002     Document Type: Article

References (26)

1. Guyatt H.L., Snow R.W. Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans R Soc Trop Med Hyg 2001, 95:569-576.
2. Ramharter M., Schuster K., Bouyou-Akotet M.K., Adegnika A.A., Schmits K., Mombo-Ngoma G., et al. Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. Am J Trop Med Hyg 2007, 77:418-422.
3. WHO: Lives at risk: malaria in pregnancy. www.who.int/features/2003/04b/en/: World Health Organization; 2003 [accessed 31 January 2011].
4. WHO: A strategic framework for malaria prevention and control during pregnancy in the African region. Geneva: World Health Organization; 2004. AFR/MAL/04/01.
5. Guyatt H.L., Snow R.W. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev 2004, 17:760-769.
6. Shulman C.E., Dorman E.K., Cutts F., Kawuondo K., Bulmer J.N., Peshu N., et al. Intermittent sulphadoxine- pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 1999, 353:632-636.
7. Parise M.E., Ayisi J.G., Nahlen B.L., Schultz L.J., Roberts J.M., Misore A., et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998, 59:813-822.
8. Schultz L.J., Steketee R.W., Macheso A., Kazembe P., Chitsulo L., Wirima J.J. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 1994, 51:515-522.
9. Newman R.D., Moran A.C., Kayentao K., Benga-De E., Yameogo M., Gaye O., et al. Prevention of malaria during pregnancy in West Africa: policy change and the power of sub regional action. Trop Med Int Health 2006, 11:462-469.
10. WHO: Strategic framework for malaria control during pregnancy in the WHO African Region. Geneva: World Health Organization; 2002.
11. Steketee R.W., Nahlen B.L., Parise M.E., Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001, 64(Suppl. 1-2):28-35.
12. Challis K., Osman N.B., Cotiro M., Nordahl G., Dgedge M., Bergström S. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Trop Med Int Health 2004, 9:1066-1073.
13. Gilles C., Jean-Yves M., Drissa B., Michel C. The importance of the period of malarial infection during pregnancy on birth weight in Tropical Africa. Am J Trop Med Hyg 2007, 76:849-854.
14. McCormick M.C. The contribution of low birth weight to infant mortality and childhood mortality. N Engl J Med 1985, 312:82-90.
15. Aitken I.W. Determination of low birth weight among the Mendi of Sierra Leone: implications for medical and socio-economic strategies. Int J Gynae Obstet 1999, 33:103-109.
16. Tutu E.O., Otupiri E., Larbi J., Brown C., Browne E., Lawson B. The effect of intermittent preventive treatment using sulphadoxine pyrimethamine in control of malaria in pregnancy: a cross-sectional study in the Offinso district of Ghana. J Public Health Epidemiol 2010, 2:53-59.
17. Sirima S.B., Cotte A.H., Konaté A., Moran A.C., Asamoa K., Bougouma E.C., et al. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupéla District, Burkina Faso. Am J Trop Med Hyg 2006, 75:205-211.
18. Mbonye A.K., Bygbjerg I., Magnussen P. Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitaemia, anaemia and low birth weight in Uganda. Int J Infect Dis 2008, 12:22-29.
19. Brabin B.J., Agbaje S.O., Ahmed Y., Briggs N.D. A birth weight nomogram for Africa, as a malaria-control indicator. Ann Trop Med Parasitol 1999, 93(Suppl. 1):S43-57.
20. Taylor H.G., Klein N., Minich N.M., Hack M. Middle-school-age outcomes in children with very low birth weight. Child Dev 2000, 71:1495-1511.
21. Garner P., Gülmezoglu A.M. Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev 2006, 4:CD000169.
22. Gies S., Coulibaly S.O., Ky C., Ouattara F.T., Brabin B.J., D'Alessandro U. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso. Am J Trop Med Hyg 2009, 80:460-469.
23. Shaheen S. Discovering the causes of atopy. BMJ 1997, 314:987-988.
24. Shaheen S.O., Sterne J.A.C., Montgomery S.M., Azima H. Birth weight, body mass index and asthma in young adults. Thorax 1999, 54:396-402.
25. Steketee R.W. Pregnancy, nutrition, and parasitic diseases. J Nutr 2003, 133:1661S-1667S.
26. Jane C. Reducing the burden of anaemia in infants and young children in malaria-endemic countries of Africa: from evidence to action. Am J Trop Med Hyg 2004, 71(Suppl. 2):25-34.